Sort   by:  
 Page size 
UnknownSoluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy.
Not available
S-EPMC10086427 | biostudies-literature
UnknownPomalidomide enhances CD8<sup>+</sup> T and NK cell mediated killing of HIV-infected cells.
Not available
S-EPMC12661362 | biostudies-literature
UnknownCombination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy.
Not available
S-EPMC8702486 | biostudies-literature
UnknownThe rapamycin-binding domain governs substrate selectivity by the mammalian target of rapamycin.
Not available
S-EPMC135667 | biostudies-literature
UnknownMemory CD4+ T cells that co-express PD1 and CTLA4 have reduced response to activating stimuli facilitating HIV latency.
Not available
S-EPMC9589005 | biostudies-literature
UnknownTargeting Ikaros and Aiolos with pomalidomide fails to reactivate or induce apoptosis of the latent HIV reservoir.
Not available
S-EPMC11915836 | biostudies-literature
UnknownEffect of high dose vitamin D3 on the HIV-1 reservoir: A pilot randomised controlled trial.
Not available
S-EPMC10518338 | biostudies-literature
UnknownThe impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy.
Not available
S-EPMC8286319 | biostudies-literature
UnknownImpact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.
Not available
S-EPMC5990417 | biostudies-literature
UnknownMultiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency.
Not available
S-EPMC7920823 | biostudies-literature
Sort   by:  
 Page size